好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cognitive Screening in Post-stroke Patients: A Survey Study Using WhatsApp
Aging, Dementia, and Behavioral Neurology
P5 - Poster Session 5 (5:30 PM-6:30 PM)
9-010
To survey the frequency of cognitive screening in neurologists and non-neurologists
Post-stroke cognitive impairment (PSCI) is common (up to 80%) and negatively impacts patients and their caregivers, although it is frequently underdiagnosed. Its appearance is related to demographic and vascular risk factors. Different specialties treat cerebrovascular disease (CVD), so we aimed to survey the frequency of cognitive screening in neurologists and non-neurologists. 
We made an electronic form (Google Forms) of 16 in-hospital and out-of-hospital cognitive screening questions for stroke patients (infarction, intracerebral and subarachnoid hemorrhage) that we sent through an instant messaging application (WhatsApp) popular in Latin America.
We got 61 responses from 7 countries. 46% of the physicians surveyed were non-neurologists. In-hospital cognitive screening in patients with cerebral infarction was similar between neurologists and non-neurologists (37.5% vs. 37.9%, respectively). Out-of-hospital neurologists performed cognitive screening more frequently (78.1% vs. 55.1%). Neurologists performed cognitive screening more frequently in patients with intracerebral and subarachnoid hemorrhages (65.6% vs 41.3%). The most used test was the MoCA test. The main reasons for not performing cognitive screening were time and physical limitations (aphasia, dysarthria, and intubation).
In-hospital screening was only performed in 1/3 of the patients by neurologists and non-neurologists. However, out-of-hospital screening was higher by neurologists. This may delay the detection of PSCI in patients without access to a neurologist. PSCI significantly affects patients, caregivers, and quality of life but is not routinely evaluated in the inpatient or outpatient setting. Due to its high prevalence, it is necessary to encourage its assessment by both the neurologist and the non-neurologist. This will allow it to be identified and treated early. 
Authors/Disclosures
Amado Jimenez Ruiz (Hospital Civil de Guadalajara Fray Antonio Alcalde)
PRESENTER
Dr. Jimenez Ruiz has nothing to disclose.
Victor M. Aguilar Fuentes (Benemérita Universidad Autónoma de Puebla) Mr. Aguilar Fuentes has nothing to disclose.
Juan A. Sotelo Ramírez Dr. Sotelo Ramírez has nothing to disclose.
Naomi N. Becerra Aguiar Ms. Becerra Aguiar has nothing to disclose.
Juan C. Ayala Alvarez, MD (Asunción 1687) Dr. Ayala Alvarez has nothing to disclose.
Ivan Roque Sanchez, MD (St barbara hospital) Dr. Roque Sanchez has nothing to disclose.
Jose L. Ruiz-Sandoval, MD Dr. Ruiz-Sandoval has nothing to disclose.